Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Palivizumab> ?p ?o }
Showing triples 1 to 73 of
73
with 100 triples per page.
- Palivizumab abstract "Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease. Palivizumab is a humanized monoclonal antibody (IgG) directed against an epitope in the A antigenic site of the F protein of RSV. In two Phase III clinical trials in the pediatric population, palivizumab reduced the risk of hospitalization due to RSV infection by 55% and 45%. Palivizumab is dosed once a month via intramuscular (IM) injection, to be administered throughout the duration of the RSV season.Palivizumab targets the fusion protein of RSV, inhibiting its entry into the cell and thereby preventing infection.".
- Palivizumab atcPrefix "J06".
- Palivizumab atcSuffix "BB16".
- Palivizumab casNumber "188039-54-5".
- Palivizumab drugbank "DB00110".
- Palivizumab fdaUniiCode "DQ448MW7KS".
- Palivizumab wikiPageID "6609299".
- Palivizumab wikiPageLength "5494".
- Palivizumab wikiPageOutDegree "8".
- Palivizumab wikiPageRevisionID "653281414".
- Palivizumab wikiPageWikiLink Category:AstraZeneca.
- Palivizumab wikiPageWikiLink Category:Biotechnology.
- Palivizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Palivizumab wikiPageWikiLink Human_respiratory_syncytial_virus.
- Palivizumab wikiPageWikiLink Intramuscular_injection.
- Palivizumab wikiPageWikiLink MedImmune.
- Palivizumab wikiPageWikiLink Monoclonal_antibody.
- Palivizumab wikiPageWikiLink Respiratory_syncytial_virus.
- Palivizumab wikiPageWikiLinkText "Palivizumab".
- Palivizumab wikiPageWikiLinkText "Synagis".
- Palivizumab wikiPageWikiLinkText "palivizumab".
- Palivizumab atcPrefix "J06".
- Palivizumab atcSuffix "BB16".
- Palivizumab casNumber "188039".
- Palivizumab chembl "1201586".
- Palivizumab chemspiderid "NA".
- Palivizumab drugbank "DB00110".
- Palivizumab eliminationHalfLife "-1728000.0".
- Palivizumab hasPhotoCollection Palivizumab.
- Palivizumab mabType "mab".
- Palivizumab medlineplus "a698034".
- Palivizumab pregnancyCategory "C".
- Palivizumab routesOfAdministration Intramuscular_injection.
- Palivizumab source "zu/o".
- Palivizumab target "RSV protein F".
- Palivizumab tradename "Synagis".
- Palivizumab type "mab".
- Palivizumab unii "DQ448MW7KS".
- Palivizumab verifiedfields "changed".
- Palivizumab verifiedrevid "458269701".
- Palivizumab wikiPageUsesTemplate Template:AstraZeneca.
- Palivizumab wikiPageUsesTemplate Template:Drugbox.
- Palivizumab wikiPageUsesTemplate Template:Immune_sera_and_immunoglobulins.
- Palivizumab wikiPageUsesTemplate Template:Monoclonals_for_infectious_disease_and_toxins.
- Palivizumab subject Category:AstraZeneca.
- Palivizumab subject Category:Biotechnology.
- Palivizumab subject Category:Monoclonal_antibodies.
- Palivizumab hypernym Antibody.
- Palivizumab type Article.
- Palivizumab type ChemicalSubstance.
- Palivizumab type Company.
- Palivizumab type Drug.
- Palivizumab type Antibody.
- Palivizumab type Article.
- Palivizumab type Chemical.
- Palivizumab type Company.
- Palivizumab type ChemicalObject.
- Palivizumab type Thing.
- Palivizumab type Q8386.
- Palivizumab comment "Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease. Palivizumab is a humanized monoclonal antibody (IgG) directed against an epitope in the A antigenic site of the F protein of RSV.".
- Palivizumab label "Palivizumab".
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs パリビズマブ.
- Palivizumab sameAs m.0gdn5s.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Palivizumab.
- Palivizumab sameAs Q412765.
- Palivizumab sameAs Q412765.
- Palivizumab wasDerivedFrom Palivizumab?oldid=653281414.
- Palivizumab isPrimaryTopicOf Palivizumab.